Antonio G. Oliver

Health Research Institute Of The Balearic Islands
Palma, PM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 361 publications

Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

Journal: Infection and immunity

Published: August 19, 2026

In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

Journal: Antimicrobial agents and chemotherapy

Published: August 19, 2026

Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.

Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.

Journal: Antimicrobial agents and chemotherapy

Published: June 15, 2026

Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

Journal: Antimicrobial agents and chemotherapy

Published: May 29, 2026

Natural and synthetic chemicals acting as enhancers of bacterial pathogenic success within the human host.

Natural and synthetic chemicals acting as enhancers of bacterial pathogenic success within the human host.

Journal: Frontiers in cellular and infection microbiology

Published: April 21, 2026

Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Journal: Antimicrobial agents and chemotherapy

Published: March 27, 2026

Comparison of Galleria mellonella, Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure Pseudomonas aeruginosa Virulence.

Comparison of Galleria mellonella, Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure Pseudomonas aeruginosa Virulence.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Identification and functional insights into new phage tail-like bacteriocins targeting Pseudomonas aeruginosa as new antimicrobials.

Identification and functional insights into new phage tail-like bacteriocins targeting Pseudomonas aeruginosa as new antimicrobials.

Journal: Microbiology spectrum

Published: March 24, 2026

PaREx: an open-source pipeline for the automated analysis of Pseudomonas aeruginosa resistomes from whole-genome sequences.

PaREx: an open-source pipeline for the automated analysis of Pseudomonas aeruginosa resistomes from whole-genome sequences.

Journal: Antimicrobial agents and chemotherapy

Published: March 16, 2026

Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes.

Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes.

Journal: The Journal of antimicrobial chemotherapy

Published: February 04, 2026

Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.

Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.

Journal: Antimicrobial agents and chemotherapy

Published: December 22, 2025

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 12, 2025

Showing 1-12 of 361

Last Updated: 09/26/2026